SCHEMBL16660271

SCHEMBL16660271

Cc1ccc(/C=C/c2nc(NC3=NNC(C)C3)cc(C(=O)NCCN3CCOCC3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 2/20 0.42
RAD52 P43351 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
TGFBR1 P36897 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16660290 0.85 DYRK1A (0.41) ALDH1A1TSHRKMT2ASMN1; SMN2LMNA
SCHEMBL10123046 0.83 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL10122991 0.83 AURKA (0.49) ALDH1A1CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL14546516 0.82 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL10123002 0.77 AURKA (0.48) ALDH1A1TSHRLMNA
SCHEMBL10122960 0.77 AURKA (0.54) ALDH1A1CYP1A2KMT2ASMN1; SMN2LMNA
SCHEMBL10123014 0.72 AURKA (0.49) ALDH1A1CYP2C9LMNAPOLBNPC1
SCHEMBL10122962 0.71 AURKA (0.49) CYP1A2CYP3A4CYP2C9TGFBR1
SCHEMBL10123026 0.70 AURKA (0.47) ALDH1A1KMT2AMEN1SMN1; SMN2LMNA
SCHEMBL13762804 0.70 IGF1R (0.43) ALDH1A1TSHRKMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928456-B1 SUBSTITUTED PYRAZOLE COMPOUNDS MIIKANA THERAPEUTICS INC (US) 2015-04-22 EP disclosed